2014
DOI: 10.1016/j.oftal.2012.06.020
|View full text |Cite
|
Sign up to set email alerts
|

Escleritis necrotizante c-ANCA positivo y esclerosis múltiple compatible con Wegener ocular: tratamiento con rituximab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…It is known to occur in both limited and severe forms of GPA and can be the ini-Open Journal of Rheumatology and Autoimmune Diseases tial symptom or occur in as high as 87% GPA patients at some time during the disease [1] [20] [21]. However, GPA with limited involvement of the orbit and/or the eye is seen rarely [22]. The Spanish registry of systemic vasculitis study reported that 24% of GPA patients had ocular involvement at diagnosis [23].…”
Section: Discussionmentioning
confidence: 99%
“…It is known to occur in both limited and severe forms of GPA and can be the ini-Open Journal of Rheumatology and Autoimmune Diseases tial symptom or occur in as high as 87% GPA patients at some time during the disease [1] [20] [21]. However, GPA with limited involvement of the orbit and/or the eye is seen rarely [22]. The Spanish registry of systemic vasculitis study reported that 24% of GPA patients had ocular involvement at diagnosis [23].…”
Section: Discussionmentioning
confidence: 99%
“…Tests for anti-phospholipid antibodies were negative, excluding the possibility of coexisting anti-phospholipid syndrome. Refractory disease was considered and she was started on second-line rituximab 375 mg/m 2 by intravenous infusion once weekly for 4 weeks, with intravenous methylprednisolone 1,000 mg/day for 3 days followed by prednisone 1 mg/kg per day [ 11 , 12 ]. Aspirin 75 mg was started daily.…”
Section: Case Presentationmentioning
confidence: 99%